Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vaxart Inc VXRT

Healthcare Biotechnology
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

Recent & Breaking News (NDAQ:VXRT)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Class Action Complaint and Application Deadline, Encourages Investors with Losses to Contact its Attorneys Now

Newsfile August 26, 2020

VAXART, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit Has Been Filed on Behalf of Shareholders of Vaxart, Inc. in the United States District Court for the Northern District of California

GlobeNewswire August 26, 2020

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vaxart, Inc. (VXRT) Investors

Business Wire August 26, 2020

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Vaxart, Inc. (VXRT) Investors

Business Wire August 26, 2020

VXRT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Vaxart, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 23, 2020

Business Wire August 26, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRT

Newsfile August 26, 2020

VAXART ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vaxart, Inc. and Encourages Investors to Contact the Firm

GlobeNewswire August 25, 2020

Vaxart Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Vaxart, Inc. To Contact The Firm

Newsfile August 25, 2020

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Vaxart, Inc. - VXRT

Business Wire August 25, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vaxart, Inc. -VXRT

PR Newswire August 25, 2020

HAGENS BERMAN FILES SECURITIES CLASS ACTION Complaint against Vaxart (VXRT) and Its Senior Executives, Encourages Investors with Losses to Contact its Attorneys Now

GlobeNewswire August 25, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vaxart, Inc. (VXRT) Investors

Business Wire August 25, 2020

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire August 25, 2020

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire August 24, 2020

HAGENS BERMAN FILES SECURITIES CLASS ACTION Complaint Against Vaxart (VXRT) and Its Senior Executives

Business Wire August 24, 2020

Scott+Scott Attorneys at Law LLP Announces Investigation into Vaxart, Inc. (VXRT)

PR Newswire August 24, 2020

Some of the World's Top Companies May be Nearing a Pandemic Treatment

Livemoney August 20, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Firm's Investigation into Possible Securities Fraud, Encourages Investors with $50K+ Losses and Persons Who May Assist to Contact Its Attorneys Now

Newsfile August 14, 2020

Shareholder Alert: Robbins LLP Announces It Is Investigating Vaxart, Inc. (VXRT) for Misleading Shareholders

Business Wire August 14, 2020

These Are Some of The Top Companies Racing to Develop a Pandemic Treatment

Livemoney August 14, 2020